Small antibacterial molecules highly active against drug-resistant Staphylococcus aureus

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• Antibiotic resistance in Staphylococcus aureus is a growing global health threat.
• Biofilm formation by S. aureus complicates treatment with conventional antibiotics.

Purpose of the Study:

• To develop a new class of small antibacterial molecules (SAMs) effective against multidrug-resistant S. aureus.
• To investigate the structure-activity relationships and therapeutic potential of these novel compounds.

Main Methods:

• Design and synthesis of SAMs with varied hydrophobic/hydrophilic balance.
• Evaluation of antibacterial activity against clinical isolates of MRSA and VRSA.
• Assessment of biofilm disruption, cytotoxicity, and plasma stability.

Main Results:

• The lead SAM compound demonstrated potent activity against MRSA and VRSA (MICs 1-4 μg mL⁻¹).
• The compound effectively killed stationary phase bacteria and disrupted established MRSA biofilms.
• Low toxicity was observed towards human erythrocytes and mammalian cells, with good stability in biological matrices.

Conclusions:

• The novel SAMs exhibit significant potential as antibacterial agents against drug-resistant S. aureus.
• Their ability to combat biofilms and their favorable safety profile warrant further development for clinical applications.